drugset / Trial / NCT03508102

Effect of Remifentanil on the Bispectral Index in Women Undergoing Caesarean Delivery Under General Anaesthesia

NCT03508102

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Patients undergoing caesarean delivery under inhalation anaesthesia are at a high risk of awareness, especially in the period before delivery. The investgators assessed the effects of remifentanil on the bispectral index (BIS) in the interval before delivery.

Timeline

Start
2015-08
Primary completion
2016-09
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.5 ug/kg
Subject Remifentanil Small molecule 1 ug/kg

Indications

No indication recorded.